07 Jan 2001

Becozyme c - España

Updated: 07 Jan 2001

Becozyme c forte 30 grageas

Profilaxis de estados carenciales de vitaminas del grupo B y vitamina C: Restricciones dietéticas, malabsorción, tratamiento.

Becozyme c Description, Presentation and Dosage

Becozyme c Description

Becozyme c Drug Class Description

Complejo b, otras asociaciones

Becozyme c Drug Description

GRAGEAS

Becozyme c Presentation

Becozyme c Presentation

Dosis usual: 1-3 grageas al día.

Becozyme c Manufacturer

ROCHE

Related Learning Zones

Oral Anticoagulation Reversal Knowledge Centre

Oral Anticoagulation Reversal Knowledge Centre

The Oral Anticoagualtion Reversal Knowledge Centre is intended to provide healthcare professionals with accurate information on the approaches to oral anticoagulation reversal for patients who experience or are at risk of significant bleeding, or require surgery. Content is arranged within illustrated and referenced sections including management of bleeding risk, oral anticoagulants, symposium highlights, key publication summaries and more.

This resource is developed by EPG Health Media (Europe) Ltd for epgonline.org in collaboration with CSL Behring, with content provided by CSL Behring.

This resource is not intended for healthcare professionals outside Europe.

Prostate Cancer Learning Hub

Prostate Cancer Learning Hub

The Prostate Cancer Learning Hub has been designed with the busy healthcare professional in mind. The resource conveniently organises a range of up-to-date education content, reference materials and decision support tools, all focussing on prostate cancer. The disease awareness section provides you with access to a Prostate Cancer Knowledge Centre, which has been developed to provide you with easy to digest best practice guidance for the treatment and management of patients with prostate cancer.

Becozyme c Dosage

Becozyme c Precautions, Reactions and Contraindications

Becozyme c Special Precautions

Related Drugs - Gastroenterologia

Back to top